drugset / Trial / NCT03187002

Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion

NCT03187002 ↗

Completed 109 enrolled Stanford University
RandomizedParallel-groupTriple-blindTreatment

Summary

High-frequency, high-intensity transcutaneous electrical nerve-stimulation (TENS) is an inexpensive and non-invasive pain control approach. TENS, pulsating electrical currents that activate underlying nerves, does not have drug interactions or risk of overdose. Cochrane review of TENS for acute pain found inconclusive evidence. One previous abortion trial comparing TENS to IV sedation only looked at pain control in the recovery room. The investigators propose a randomized controlled trial comparing TENS to IV sedation (in conjunction with local anesthesia) among women presenting for first-trimester surgical abortion. Primary outcome will be perceived pain by Visual Analogue Scale (VAS) during aspiration.

Timeline

Start
2018-01-18
Primary completion
2019-10-31
Completion
2019-10-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified — Intravenous
Comparator Midazolam Small molecule — Intravenous

Indications

No indication recorded.